Skip to main content
SpringerLink
Log in

Treatment of Severe Hypertension in Children with Renal Disease

  • Chapter
Acute Renal Disorders and Renal Emergencies

Part of the book series: Developments in Nephrology ((DINE,volume 7))

Abstract

Severe hypertension and hypertensive emergencies in children most often occur in association with secondary forms of high blood pressure and may develop in children with previously unrecognized disease or as a sudden change in children with known hypertension. The term hypertensive crisis or hypertensive emergency is used to denote a clinical situation in which the blood pressure has been elevated for some period of time and ought to be lowered over minutes, or hours depending on the patient’s clinical status. The clinical presentation of hypertensive emergencies varies. Life threatening hypertensive symptoms, such as acute heart failure, pulmonary edema or neurologic changes require immediate lowering of the blood pressure. (Table I)

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Pascual, A.V.: Hypertensive Crises: Diagnosis and Strategies in Treatment, Hospital Medicine, January 1981, pp 43 – 59.

    Google Scholar 

  2. Byron, F.B: The pathogenesis of hypertensive encephalopathy and its relation to the malignant phase of hypertension-experimental evidence from the hypertensive rat. Lancet 2: 201, 1954.

    Article  Google Scholar 

  3. Reinmuth, O.M., Beteta. E., and Scheinberg, P.: Total cerebral blood flew in cerebral vascular disease in relation to hypertension. Neurology 16: 815, 1966.

    Google Scholar 

  4. Strandgaard, S., MacKenzie, E.T., Sengupta, D., et al.:Upper limits of autoregulation of cerebral blood flew in the baboon. Circ. Res. 34: 435, 1974.

    CAS  Google Scholar 

  5. Cuneo, R.A., and Caronna, J.J.: The neurologic complications of hypertension. Med. Clin. North Am. 61: 565, 1977.

    CAS  Google Scholar 

  6. Calhoun, J.: Ocular manifestations in disorders of the blood, blood vessels, heart, and lungs, and in the histiocytosis syndrome. In: Harley, R.D. (ed) Pediatric Ophthalmology. W.B. Saunders, 1975, p 656.

    Google Scholar 

  7. Kincaid-Smith, P.: Malignant Hypertension, Cardiovascular Reviews & Reports, Is 41, 1980.

    Google Scholar 

  8. Leuman, E.P.: Blood pressure and hypertension in childhood and adolescence. In: Frick, H. von P., von Harnack, G.A., Martini, G.A., Prader, A., Schoen, R. and Wolff, H.P. (eds): Advances in Internal Medicine and Pediatrics. Bd 43 Springer-Verlag 1979, p 111.

    Google Scholar 

  9. Volhard, F., Fahr, K.T.: Die Brightsche Nierenkranheit. Springer-Verlag, 1914.

    Google Scholar 

  10. Keith, N.M., Wagener, H.P., Parker, N.W.: Seme different types of essential hypertension: Their course and prognosis. Am. J. Med. Sci. 197: 332, 1939.

    Article  Google Scholar 

  11. Kincaid-Smith, P., McMichael, J., Murphy, E.A.: The clinical course and pathology of hypertension with papilledema (malignant hypertension). J. Med. 105 (new series 27): 117, 1958.

    Google Scholar 

  12. Keith, T.A. III: Hypertension Crisis - Recognition and Management. JAMA, 237: 1570, 1977.

    Article  PubMed  Google Scholar 

  13. Report of the Task Force on Blood Pressure Control in Children; Prepared by the National Heart, Lung, and Blood Institute’s Task Force on Blood Pressure Control in Children. Pediatrics, 59: 797, 1977.

    Google Scholar 

  14. Guidelines for the Evaluation and Management of the Hypertensive Patient: U.S. Department of Health, Education, and Welfare, U.S. Public Health Service, National Institutes of Health, DHEW Publication no. (NIH) 74–593, Sept. 1, 1973.

    Google Scholar 

  15. Laragh, J.H.: Vasoconstriction-volume analysis for understanding and treating hypertension: the use of renin and aldosterone profiles. Am. J. Med. 55: 261, 1973.

    Article  PubMed  CAS  Google Scholar 

  16. Hiner, L.B., and Gruskin, A.B.: The physiology of blood pressure regulating normal and abnormal. Pediatr. Ann. 6: 373, 1977.

    CAS  Google Scholar 

  17. Moser, M.: Management of Hypertensive Emergencies. Drug Therapy, May 1974, pp 143 - 157.

    Google Scholar 

  18. Bailie, M. D., Mattiolo, L. F.: Hypertension: Relationships between pathophysiology and therapy, J.Pediatr. 95: 789, 1980.

    Google Scholar 

  19. Naranjo, G., Scmani, P., and Elberg, A.J: The challenge of a pediatric hypertensive crisis- Drug Therapy, April 1979, pp 130 – 141.

    Google Scholar 

  20. McLain, L.G.: Therapy of Acute Severe Hypertension in Children, JAMA, 239: 755, 1978.

    Article  PubMed  CAS  Google Scholar 

  21. Ranee, C.P., Aibus, G.S., Balfe, J.W., Kooh, S.W.: Persistent Systemic Hypertension in Infants and Children, Pediatr. Clin.North Amer. 21: 801, 1974.

    Google Scholar 

  22. Perry, H.M.: The Management of Malignant Hypertension. Drug Therapy, October 1971, pp 33 – 43.

    Google Scholar 

  23. Finnerty, F.A.: Hypertensive Crisis. JAMA 229: 1479, 1974.

    Article  PubMed  Google Scholar 

  24. AMA Committee on Hypertension: The Treatment of Malignant Hypertension and Hypertensive Emergencies. JAMA, 228: 1673, 1974.

    Article  Google Scholar 

  25. Mendlcwitz, M.: Management of Hypertensive Emergencies. Hospital Medicine, December 1979, pp 63 – 67.

    Google Scholar 

  26. Reisman, L. and Selden, R.V: Management of Systemic Hypertension in Children. Pediatr. Ann. 11: 604, 1982.

    CAS  Google Scholar 

  27. Loggie, J.M.H.: Hypertension in Children and Adolescents. J. Pediatr. 74? 640, 1969.

    Google Scholar 

  28. Powell, H.R., Rotenberg, E., Williams, A.L., et al.: Plasma renin activity in acute poststreptococcal glomerulonephritis and the haemolytic-uremic syndrcrne. Arch. Dis. Child. 49: 802, 1974.

    CAS  Google Scholar 

  29. Repetto, H.A., Lewy, J.E., Brando, J.L., et al.: The renal functional response to furosemide in children with acute glomerulonephritis. J. Pediatr. 80: 660, 1972.

    CAS  Google Scholar 

  30. Gordillo-Paniagua, G., Velasquez-Jones, L., Martini, R., et al.: Sodium nitroprusside treatment for severe arterial hypertension in children. J. Pediatr. 87: 799, 1975.

    Article  PubMed  CAS  Google Scholar 

  31. Etteldorf, J.N., Smith, J.D., and Johnson, C.: The effect of reserpine and its combination with hydralazine on blood pressure and renal hemodynamics during the hypertensive phase of acute nephritis in children. J. Pediat. 48: 129, 1956.

    Article  PubMed  CAS  Google Scholar 

  32. Lowenthal, D.T, Pennock, R., Likoff, W. and Onesti, G: Therapy of Hypertension in the Dialysis Patient, in Flanagement of the Cardiac Patient v/ith Renal Failure. SA Davis Co., 1981, P 155.

    Google Scholar 

  33. Vidt, D.G.: The Management of Hypertension in Renal Failure. The Kidney 9: 15, 1976.

    Google Scholar 

  34. Garrett, B.N.: Treatment of Hypertension in Patients with Chronic Renal Failure. Contemporary Dialysis, pp 21–33, April, 1981.

    Google Scholar 

  35. Onesti, G., Swartz, C., Remirez, R. and Brest, A.N.: Bilateral nephrectomy for control of hypertension in uremia. Trans. Amer. Soc. Artif. Intern. Organs 14: 361, 1969.

    Google Scholar 

  36. Vertes, V., Cangiano, J.L., Berman, L.B., Gould, A.: Hypertension in end-stage renal disease. Netf Eng. J. Med. 280: 978, 1969.

    CAS  Google Scholar 

  37. Weidmann, P., Maxwell, M.H., Lupu, A.N., Lanin, A.J., and Massry, S.G.: Plasma renin activity and blood pressure in terminal renal failure. Net-7 Eng. J. Med. 285: 757, 1971.

    CAS  Google Scholar 

  38. Gruntzig, A., Vetter, W., Meier, E.: Treatment of Renovascular Hypertension v/ith Percutaneous Transluminal Dilation of a Renal Artery Stenosis. Lancet. 1: 801, 1978.

    Article  PubMed  CAS  Google Scholar 

  39. Vaughan, E.D., Jr., Sos, T.A., Sniderraan, K.W., Pickering, T.G., Case, D.B., Sealey, J.H., Laragh, J.H.: Renal Venous Renin Secretory Patterns Before and After Percultaneous Transluminal Angioplasty. In: Laragh, J.H., Buhler, F.R., Seldin, D.W. (eds). Frontiers in Hypertension Research. New York: Springer-Ver lag, lybl, p 173.

    Google Scholar 

  40. Vaughan, E.D., Jr., Buhler, F.R., Laragh, J.H., Sealey, J.E., Baer, L., Bard, R.H.: Renovascular Hypertension: Renin Measurements to Indicate Hypersecretion and Contralateral Suppression, Estimate Renal Plasira Flow and Score for Surgical Curability. Am. J. Med., 55: 402, 1973.

    Article  PubMed  Google Scholar 

  41. Ehrlich, R.M.: Vesicoureteral Reflux: A surgeon’s perspective. Pediatr. CI. N.Airer. 28: 827, 1982.

    Google Scholar 

  42. Koch-Weser, J., Hydralazine: N.Engl.J.Med. 295: 320, 1976.

    Article  CAS  Google Scholar 

  43. Freis, E.D., Rose J.C., Higgins, T.F., et al: The hemodynamic effects of hypotensive drugs in man. IV. 1-hydrazinophthalazine. Circulation 0: 199, 1953.

    CAS  Google Scholar 

  44. Perry, H.M., Jr: Late toxicity to hydralazine resembling systemc lupus erythematosus or rheumatoid arthritis. Am. J.Med. 54: 58, 1973.

    Article  PubMed  Google Scholar 

  45. Sinaiko, A.R., Mirkin, B.L.: Clinical pharmacology of antihypertensive drugs in children. Pediatr.Clin.North.Am. 25 (1): 146, 1978.

    Google Scholar 

  46. VanZwierten, P.A.: The central action of antihypertensive drugs mediated via central alpha receptors. J.Pham.Pharmacol. 25: 89, 1973.

    Google Scholar 

  47. Mohaimied, S. et al. -.Effect of methyldopa on plasma renin activity in man. Cir.Res. 25: 543, 1969.

    Google Scholar 

  48. Furhoff, A: Adverse reactions with methyldopa. Acta Med.Scand. 203: 425, 1978.

    Article  PubMed  CAS  Google Scholar 

  49. Koch-Weser, J.: Diazoxide. N.Engl. J jyied. 294: 1271, 1976.

    CAS  Google Scholar 

  50. Powell, W.J. Jr., Green, R.M., Whiting R.B., et al.:Action of diazoxide on skeletal muscle vascular resistance. Circ.Res. 28: 167, 1971.

    PubMed  CAS  Google Scholar 

  51. Johnson, B.F.: Diazoxide and renal function in man. Clin.Pharmacol.Ther. 12: 815, 1971.

    PubMed  CAS  Google Scholar 

  52. Boerth, R.C. and Long, W.R.: Dose-Response Relation of Diazoxide in Children with Hypertension. Circulation, 56, 1062, 1977.

    PubMed  CAS  Google Scholar 

  53. Ogilvie, R.I., Nadeau, J.H., Sitar, D.S.: Diazoxide Concentration-Response Relation in Hypertension. Hypertension 4: 167, 1982.

    PubMed  CAS  Google Scholar 

  54. O’Malley, K., Vesasco M.,Pruitt, A., et al.: Decreased plasma protein binding of diazoxide in uremia. Clin. Pharmacol. Ther. 18: 53, 1975.

    PubMed  Google Scholar 

  55. Sellers, E.M., Koch-Weser, J: Displacement of warfarin frcm human albumin by diazoxide and ethacrynic, mefenamic, and nalidixic acids. Clin. Pharmacol. Ther. 11: 524, 1970.

    PubMed  CAS  Google Scholar 

  56. Finnerty, F.A.,Jr., Davidov, M., Mroczek, W.J., Gavillovich, L.: Influence of extracellular fluid volume on response to antihypertensive drugs. Clin. Res. 27 (suppl 1): 71, 1970.

    Google Scholar 

  57. Charles, M.A., Danforth E. Jr: Nonketoacidotic hyperglycemia and coma during intravenous diazoxide therapy in uremia. Diabetes 20: 501, 1971.

    PubMed  CAS  Google Scholar 

  58. Palmer, R.F., and Lasseter, K.C.: Sodium nitroprusside. N. Engl. J. Med. 292: 294, 1975.

    Article  PubMed  CAS  Google Scholar 

  59. Cohn, J.N.: Blood pressure and cardiac performance. Am.J.Med. 55: 351, 1973.

    Article  PubMed  CAS  Google Scholar 

  60. Luderer, J.R., Hayes, A.H., Dubynsky, O., et al.: Long-term administration of sodium nitroprusside in childhood. J. Pediatr. 91: 490, 1977.

    Article  PubMed  CAS  Google Scholar 

  61. Novak, D.S., Glassock, R.J., Solomon, D.H., and Maxwell, M.H.: Hypothyroidism following prolonged sodium nitroprusside therapy- Am.J. Med.Sci. 248: 129, 1964.

    Article  Google Scholar 

  62. Page, I.H., Corcoran, A.C., Dustan, H.P., and Koppanyi, T: Cardiovascular actions of sodium nitroprusside in animals and hypertensive patients. Circulation 11: 188, 1955.

    PubMed  CAS  Google Scholar 

  63. Danzig, L.E.: Dynamics of thiocyanate dialysis. N. Engl. J. Med. 252: 49, 1955.

    Article  PubMed  CAS  Google Scholar 

  64. Goldstein, F., and Rieders, F.: Conversion of thiocyanate to cyanide by an erythrocytic enzyme. Am.J.Physiol. 173: 287, 1953.

    PubMed  CAS  Google Scholar 

  65. Elberg, A.J., Gorman, H.M., Baker, R., et al.: Prolonged nitroprusside and intermittent hemodialysis as therapy for intractable hypertension. Am. J. Dis. Child 132: 988, 1978.

    PubMed  CAS  Google Scholar 

  66. Posner, M.A., Rodkey, F.L., and Tobey, R.E.: Nitroprusside-induced cyanide poisoning: Antidotal effect of hydroxycobaiamin. Anesthesiology 44: 330, 1976.

    Article  PubMed  CAS  Google Scholar 

  67. Zawada, E.T., Maxwell, M.H., Marks, L.S., Lee, D.B., and Kaufman, J.J: The diagnostic and therapeutic uses of saralasin in renal transplant hypertension. J.Urol. 123: 148, 1980.

    PubMed  Google Scholar 

  68. Ruley, E.J., Bock, G.H., and Smith, D.: Use of continuous saralasin infusion to control hypertension. J. Pediatr. 101: 1013, 1982.

    Article  PubMed  CAS  Google Scholar 

  69. Pettinger, W.A.: Minoxidil and the Treatment of Severe Hypertension- N.Engl.J.Med, 303: 922, 1980.

    CAS  Google Scholar 

  70. Lewy, P.R.: The Management of Resistant Hypertension - The Role of Minoxidil, (eds) Gruskin, A.B., and Norman M.E., In: Developments in Nephrology 3. Pediatric Nephrology. Boston: Martinus Nijhoff, 1981, p. 416.

    Google Scholar 

  71. Sinaiko, A.R., O’Dea, R.F., Mirkin, B.L.: Clinical response of hypertensive children to long-term minoxidil therapy. J Cardiovasc. Pharmacol. 2: Suppl: 181, 1980.

    Google Scholar 

  72. Sinaiko, A.R., and Mirkin, B.L.: Management of severe childhood hypertension with minoxidil: a controlled study. J-Pediatr-91: 138, 1977.

    Google Scholar 

  73. Pennisi, A.F., Bernstein, B.H., Takahashi, M., et al.:Minoxidil therapy in children with severe hypertension, J.Pediatr. 90: 813, 1977.

    Article  PubMed  CAS  Google Scholar 

  74. Puri, H.C., and Potter, D.E.: Long Term Minoxidil Therapy in Children with Refractory Hypertension- Pediatr - Res. 14: 1009, 1980.

    Google Scholar 

  75. Martin, W.B., Spodick, D.H., Zins, G.R.: Pericardial disorders occurring during open-label study of 1,869 severely hypertensive patients treated with minoxidil. J.Cardiovasc.Pharmacol. 1980? 2: Suppl: 227, 1980.

    Google Scholar 

  76. O’Malley, K., Velasco, M., Wells, J., McNay, J.L.: Control plasma renin activity and changes in sympathetic tone as determinants of minoxidil-induced increase in plasma renin activity. J.Clin.Invest. 55: 230, 1975.

    Article  PubMed  Google Scholar 

  77. Pettinger, W.A., Mitchell, H.C.: Renin release, saralasin and the vasodilator-beta-blocker drug interaction in man. N. Engl. J-Med. 292: 1214, 1975.

    Article  PubMed  CAS  Google Scholar 

  78. Mitchell, H.C., Pettinger, W.A.: The hypernoradrenergic state in vasodilator drug-treated hypertensive patients; effect of clonidine. J.Cardiovasc.Pharmacol. 2: 1, 1980.

    Article  PubMed  CAS  Google Scholar 

  79. Makker, S.P., and Moorthy, B.: Rebound hypertension following minoxidil withdrawal- J.Pediatr. 96: 762, 1980.

    CAS  Google Scholar 

  80. Vidt, D.G., Bravo, E.L., and Fouad, F.M.: Captopril, N. Engl. J.Med. 306: 214, 1982.

    Article  CAS  Google Scholar 

  81. Murthy, V.S., Waldron,T.L., Goldberg, M.E.: The mechanism of bradykinin potentiation after inhibition of angiotensin-converting enzyme (SQ 14,225) in conscious rabbits. Circ. Res. 43: Part 2: 1-46–5, 1976.

    Google Scholar 

  82. Sullivan, J.M., Ginsburg, B.A., Ratts, T.E., et al.: Hemodynamic and antihypertensive effects of captopril, an orally active angiotensin converting enzyme inhibitor. Hypertension. 1: 397, 1979.

    PubMed  CAS  Google Scholar 

  83. Tarazi, R.C., Bravo, E.L., Fouad, F.M., Omvik, P., Cody, R.J. Jr.: Hemodynamic and volume changes associated with captopril. Hypertension. 2: 576, 1980.

    PubMed  CAS  Google Scholar 

  84. Case, D.B., Atlas, S.A., Laragh, J.H., et al.: Clinical experience with blockade of the renin-angiotensin-aldosterone system by an oral Converting enzyme inhibitor (SQ 14,225, captopril) in hypertensive patients. Prog.Cardiovasc.Dis. 21: 195, 1978.

    Article  PubMed  CAS  Google Scholar 

  85. Textor, S.C., Bravo, E.L., Fouad, F.M., and Tarazi, R.C.: Hyperkalemia in azotemic patients during angiotensin converting enzyme inhibition and aldosterone reduction with captopril. Amer. J. Med. 73: 719, 1982.

    Article  CAS  Google Scholar 

  86. Oberfield, S.E., Rapaport, R., Levine, L.S., New, M.I.: Long-Term Treatment of Childhood Hypertension with Captopril- Pediat. Ann. 11: 614, 1982.

    CAS  Google Scholar 

  87. Waeber, B., Guignard, J.P., Brunner, H.R. et al.:Treatment of severe renal hypertension in a child with an inhibitor of the angiotensin converting enzyme (SQ 14225). Helv-Paediatr.Acta-40(suppl): 10, 1978.

    Google Scholar 

  88. Oberfield, S.E., Case, D.B., Levine, L.S., et al.:Brief clinical and laboratory observations: Use of the oral angiotensin I-converting enzyme inhibitor (captopril) in childhood malignant hypertension. J. Pediatr. 95: 641, 1979.

    Article  PubMed  CAS  Google Scholar 

  89. Bacri, J.L., Dechaux, M., Gingnadoux, M.F., et al.; Short term response and long term management with captopril in severe hypertention (HT) of children. Pediatr.Res. 14: 1009, 1980.

    Article  Google Scholar 

  90. Friedman, A., Chesney, R.W., Ball, D., et al.:Effective use of captopril (angiotensin I-converting enzyme inhibitor) in severe childhood hypertension. J.Pediatr 97: 664, 1980.

    Article  PubMed  CAS  Google Scholar 

  91. Callis, L., Vila, A., Vilaplana E., and Castello, F.: Effect of Captopril in patients on chronic hemodialysis. Int. J. Pediatr.Neph. 3: 111, 1982.

    Google Scholar 

  92. Ploos van Amstel, S.L.B. and Abbad, F.C.B.;Long-term treatment of severe hypertension with Captopril. Int. J. Pediatr.Neph. 3: 107, 1982.

    Google Scholar 

  93. Chennavasin, P., Sciwell, R., Brater, D.C. and Liang, W.M.M.: Pharmacodynamic analysis of the furosemide-probenecid interaction in man. Kid. Int. 16: 187, 1979.

    CAS  Google Scholar 

  94. Rubb, W.: Pharmacokinetics and Pharmacodynamics of Lasix. Scot. Med. J. 19: 5, 1974.

    Google Scholar 

  95. Dikshit, K., Vyden, J.K., Forrester, J.S., et al.:Renal and extrarenal hemodynamic effects of furosemide in congestive heart failure after acute myocardial infarction. New.Eng.J.Med. 288: 1087, 1973.

    Article  PubMed  CAS  Google Scholar 

  96. De Rubertis, F.R., Michells, M.F., Beck, N., Davis, B.B.: Complications of diuretic therapy: Severe alkalosis and syndrome resembling inappropriate secretion of antidiuretic hormone. Metabolism 19: 709, 1970.

    Article  CAS  Google Scholar 

  97. Steele, T.H., Rieselbach, R.E.: Renal handling of urate and other organic anions, (eds) Brenner, B.M., and Rector, F.C., In: The Kidney. WB Saunders, 1976, p 460.

    Google Scholar 

  98. Schwartz, G.H., David, D.S., Riggio, R.R., et al.:Ototoxicity Induced by Furosemide, New. Engl.’J. Med. 282: 1413, 1970.

    Article  CAS  Google Scholar 

  99. Mudge, G.H.: Diuretics and other agents employed in the mobilization of edema fluid, (eds) Gilman, A.G., Goodman, L.S., and Gilman, A. In: The pharmacological basis of therapeutics, 6th edition. McMillan Co., 1980, p. 906.

    Google Scholar 

  100. Seedat, Y.K.: High-Dose Furosemide (Lasix) in Renal Insufficiency. S. Arf. Med. J. 46: 1371, 1972.

    CAS  Google Scholar 

  101. Huang, C.M., Atkinson, A.J., Levin, M., et al.: Pharmacokinetics of furosemide in advanced renal failure. Clin. Pharmacol Ther. 16: 659, 1972.

    Google Scholar 

  102. Wollam, G.L., Tarazi, R.C., Bravo, E.L. and Dustanr H.P.: Diuretic potency of combined hydrochlorothiazide and furosemide therapy in patients with azotemia. Amer. J. Med., 72: 929, 1982.

    Article  CAS  Google Scholar 

Download references

Authors
  1. Alan B. Gruskin
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. H. Jorge Baluarte
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Martin S. Polinsky
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Bruce A. Kaiser
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Sharon A. Perlman
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Bruce Z. Morgenstern
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Division of Pediatric Nephrology, School of Medicine, University of Miami, Miami, Florida, USA

    José Strauss MD

Rights and permissions

Reprints and permissions

Copyright information

© 1984 Martinus Nijhoff Publishing, Boston

About this chapter

Cite this chapter

Gruskin, A.B., Baluarte, H.J., Polinsky, M.S., Kaiser, B.A., Perlman, S.A., Morgenstern, B.Z. (1984). Treatment of Severe Hypertension in Children with Renal Disease. In: Strauss, J. (eds) Acute Renal Disorders and Renal Emergencies. Developments in Nephrology, vol 7. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-3822-2_14

Download citation

  • DOI: https://doi.org/10.1007/978-1-4613-3822-2_14

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-3824-6

  • Online ISBN: 978-1-4613-3822-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation